MyAverix Finance
SHE · Healthcare
Hebei Changshan Biochem Pharma (300255)
Biotechnology
Hebei Changshan Biochem Pharma (300255) is listed on SHE in the Healthcare sector. Industry: Biotechnology. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 300255
Hebei Changshan Biochem Pharma (300255) — FAQ
What is 300255's P/E ratio?
The price-to-earnings (P/E) ratio for Hebei Changshan Biochem Pharma (300255) is 18.00 (data as of 2026-03-23).
Does Hebei Changshan Biochem Pharma pay a dividend?
Dividend yield is not available in the current snapshot for Hebei Changshan Biochem Pharma (300255). Check the MyAverix Finance app for the latest dividend data.
What sector is Hebei Changshan Biochem Pharma in?
Hebei Changshan Biochem Pharma (300255) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 300255 listed on?
300255 is listed on SHE.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.